Late Phase Drug Development Europe 2013

Topics

• Regulatory environment
• Strategic drivers
• Enabling technologies in late stage development
• Registries and results databases
• Best practice case studies
• Operational issues in late stage study management

Who should Attend

Delegates from Biotechnology, Pharmaceutical and Contract Research industries involved in Clinical research, Clinical trials, Surveillance, Post marketing, Pharmacoepidemiology, Medical Affairs, Clinical Data Management, Investigator sponsored studies, Pharmacovigilance, Drug development and Risk management.